The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Patent Foramen Ovale in Patients with Stroke
Lechat, P., Mas, J. L., Lascault, G., Loron, P., Theard, M., Klimczac, M., Drobinski, G., Thomas, D., & Grosgogeat, Y. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181802 · Cited by 1,657
Mas, J.-L., Arquizan, C., Lamy, C., Zuber, M., Cabanes, L., Derumeaux, G., & Coste, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011503 · Cited by 1,361
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Mas, J.-L., Derumeaux, G., Guillon, B., Massardier, E., Hosseini, H., Mechtouff, L., Arquizan, C., Béjot, Y., Vuillier, F., Detante, O., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705915 · Cited by 1,183
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Søndergaard, L., Kasner, S. E., Rhodes, J. F., Andersen, G., Iversen, H. K., Nielsen-Kudsk, J. E., Settergren, M., Sjöstrand, C., Roine, R. O., Hildick-Smith, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707404 · Cited by 1,137
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
Saver, J. L., Carroll, J. D., Thaler, D. E., Smalling, R. W., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610057 · Cited by 1,127
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Furlan, A. J., Reisman, M., Massaro, J., Mauri, L., Adams, H., Albers, G. W., Felberg, R., Herrmann, H., Kar, S., Landzberg, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009639 · Cited by 1,060
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
Carroll, J. D., Saver, J. L., Thaler, D. E., Smalling, R. W., Berry, S., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301440 · Cited by 983
Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies
Overell, J. R., Bone, I., & Lees, K. R. (2000) · Neurology · doi:10.1212/wnl.55.8.1172 · Cited by 936
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Meier, B., Kalesan, B., Mattle, H. P., Khattab, A. A., Hildick-Smith, D., Dudek, D., Andersen, G., Ibrahim, R., Schuler, G., Walton, A. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211716 · Cited by 920
PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS
Webster, M. W. I., Smith, H. J., Sharpe, D. N., Chancellor, A. M., Swift, D. L., Bass, N. M., & Glasgow, G. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92944-3 · Cited by 823
Cited by
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020
Gladstone, D. J., Lindsay, M. P., Douketis, J., Smith, E. E., Dowlatshahi, D., Wein, T., Bourgoin, A., Cox, J., Falconer, J. B., Graham, B. R., et al. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.127 · Cited by 168
Metadata
- Authors
- Lee, P. H., Song, J.-K., Kim, J. S., Heo, R., Lee, S., Kim, D.-H., Song, J.-M., Kang, D.-H., Kwon, S. U., Kang, D.-W., Lee, D., Kwon, H. S., Yun, S.-C., Sun, B. J., Park, J.-H., Lee, J.-H., Jeong, H. S., Song, H.-J., Kim, J., & Park, S.-J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 71
- Issue
- 20
- Pages
- 2335-2342
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2790529755
- Cited by
- 588
- References
- 20
- FWCI
- 40.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.